Life Sciences

Unique Risks and Rewards

'; } else if (is_page(array(116,114))){ echo '

SOFTWARE AND WEB

'; } else if (is_page(array(197, 199, 450))) { echo '

EXPERTS IN LEGISLATIVE AND PUBLIC POLICY MATTERS

'; } ?>

R&D, DIAGNOSTICS, BIOINFORMATICS, BIOSECURITY, PUBLIC HEALTH, ENVIRONMENTAL TESTING AND HEALTH-IT MARKETS

  • About Us
    • 0, 'show_date' => '', 'date_format' => get_option('date_format'), 'child_of' => 0, 'exclude' => '61', 'include' => '', 'title_li' => '', 'echo' => 1, 'authors' => '', 'sort_column' => 'menu_order', 'link_before' => '', 'link_after' => '', 'walker' => '' ); //$pages = get_pages($args); wp_list_pages( $args ); } //print_r($pages); ?>

Life Sciences Overview

Life SciencesWe negotiate deals at the cutting edge of developing and commercializing technology and tools for scientific research and testing:   Genetic Sequencing and Analysis, Bioinformatics Tools and Datasets, Assays and Instruments.  We licensed Celera Genomics’ datasets and tools and we worked with public health agencies globally during the H1N1 influenza pandemic.  In addition, we are uniquely able to help clients sift through the overlay of intellectual property and privacy rights in research and patient data.